Savara Pharmaceuticals’ AeroVanc for Cystic Fibrosis Patients Achieves…

Savara Pharmaceuticals’ AeroVanc for cystic fibrosis patients achieves positive results in Phase I clinical trial.

(PRWeb April 26, 2012)

Read the full story at http://www.prweb.com/releases/2012/4/prweb9444575.htm


Comments are closed.